Building further on the success of the pocket guides for adult and paediatric allergic rhinitis, the European Forum for Research & Education in Allergy & Airway Diseases (EUFOREA) in collaboration with global key opinion leaders in the field of chronic inflammatory airways disease, has developed a CRS pocket guide with a new treatment algorithm.
The background of this article focuses on European patients with chronic rhinosinusitis with nasal polyps (CRSwNP) that have had only limited occasions to unite to have their voices heard, hence missing the opportunity to contribute to the improvement of CRSwNP care.
Uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) is the most bothersome phenotype of chronic rhinosinusitis, as is typically characterized by a type 2 inflammatory reaction and by comorbidities, including asthma, nonsteroidal anti-inflammatory drug–exacerbated respiratory disease and allergies.
Patients with asthma, CRSwNP and AD have shared unmet needs that need to be addressed by physicians, the academic community and health policymakers. This survey provides unique recommendations made by patients for the implementation of better care.
